StockNews.AI
LFWD
StockNews.AI
172 days

Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025

1. Lifeward will release Q4 and fiscal year-end results on March 7, 2025. 2. CEO and CFO to discuss financial results in a conference call at 8:30 a.m. EST. 3. The company's innovative medical technology aims to assist individuals with disabilities. 4. Lifeward's products include ReWalk Exoskeleton and AlterG Anti-Gravity system. 5. The company operates in the U.S., Israel, and Germany since its founding in 2001.

4m saved
Insight
Article

FAQ

Why Bullish?

The upcoming earnings call could positively influence investor sentiment, similar to prior quarterly results that led to price increases during previous earnings announcements.

How important is it?

The scheduled earnings call is crucial for market expectations and potential future performance indications, driving immediate investor interest.

Why Short Term?

The earnings call will provide immediate insights; positive results may yield quick market reactions.

Related Companies

SPYIBBMDT
February 28, 2025 08:00 ET  | Source: Lifeward Ltd. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a  global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company will release its fourth quarter and fiscal year-end financial results before the markets open on Friday, March 7, 2025. Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EST to discuss the financial results. To access the call, analysts and investors may utilize the following: Toll free (U.S.)1-833-316-0561International (U.S)1-412-317-0690Germany0800-6647650Israel1-80-9212373Access CodePlease reference the “Lifeward Earnings Call” The conference call will be webcast live and the webcast can be accessed through a link on the Company’s website at GoLifeward.com in the "Investors" section, or through the following link: https://edge.media-server.com/mmc/p/9u4xjdep. An archived webcast will also be available on the company's website. About Lifeward Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany. For more information on the Lifeward mission and product portfolio, please visit GoLifeward.com. Lifeward®, ReWalk®, ReStore® and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.    Lifeward Media Relations:Kathleen O’DonnellVP Marketing & New Business DevelopmentLifeward Ltd.E: media@golifeward.comLifeward Investor Contact:Mike LawlessChief Financial OfficerLifeward Ltd.E: ir@golifeward.com

Related News